Clinical Trial Update: Comparative Study Between IVI of Ranibizumab with and Without Prior ACP in Patients with DME Using OCT-A [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating intravitreal ranibizumab with versus without prior ACP in diabetic macular edema using OCT-A; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Ain Shams University | Conditions: Diabetic Macular Edema | Phase 4 | Status: COMPLETED